Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Is The Tuberculosis Diagnostics Market Expected To Grow In Terms Of Size?
In recent times, there has been a notable growth in the size of the tuberculosis diagnostics market. The market, which stood at $2.21 billion in 2024, is anticipated to increase to $2.34 billion in 2025, evidencing a compound annual growth rate (CAGR) of 5.9%. The historical growth of this market can be traced back to the escalation in tuberculosis cases, augmentation in healthcare expenditure, expansion in healthcare facilities, and an upward trend in the uptake of nucleic acid testing.

Expectations are high for the tuberculosis diagnostics market to experience significant growth in the coming years, with a projection to reach $3.15 billion in 2029 and a compound annual growth rate (CAGR) of 7.7%. Factors contributing to this predicted surge include robust government backing, an upsurge in FDA approvals for tuberculosis diagnostics, intensified research and development efforts, and the emergence of drug-resistant TB. The upcoming trends forecasted for this period comprise the utilization of next-generation sequencing (NGS) platforms for TB diagnostics, innovative products, t-cell tests for TB infection, artificial intelligence-powered tuberculosis diagnostics, deployment of portable devices, and synergies between government entities and manufacturers.

Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8165&type=smp

What Market Forces Are Contributing To The Growth Of The Tuberculosis Diagnostics Market?
The tuberculosis diagnostics market is experiencing an upward trend due to the escalating incidence of tuberculosis. Being an infectious ailment, tuberculosis majorly attacks the lungs and can escalate to extreme conditions. Tuberculosis proliferates through the act of coughing and sneezing, which disperse microscopic germs in the air. These diagnostic tools for tuberculosis significantly contribute to patient detection, endorsing earlier diagnoses and detection of ailments. As an exemplification, the Centers for Disease Control and Prevention, a significant public health institution based in the US, reported in March 2023 that there were 8,300 instances of tuberculosis in the US in 2022, marking an increase from the 7,874 cases of 2021. Consequently, this surge in tuberculosis occurrence bolsters the expansiveness of the tuberculosis diagnostics market. Hence, the growing prevalence of tuberculosis is propelling the development of the tuberculosis diagnostics market.

How Is The Tuberculosis Diagnostics Market Segmented Across Key Categories?
The tuberculosis diagnosticsmarket covered in this report is segmented –

1) By Test Type: Radiographic Tests, Nucleic Acid Testing, Cytokine Detection Tests, Drug Resistance Tests, Skin Test / Mantoux Test (TST), Blood/Serology Test, Smear Microscopy Tests, Cell Culture-Based Tests, Other Test Types
2) By Disease Stage: Latent Tuberculosis, Active Tuberculosis
3) By End-User: Hospitals And Diagnostic Laboratories, Physician’s Office Laboratories, Reference Laboratories, Academics And Research Facilities

Subsegments:
1) By Radiographic Tests: Chest X-rays, CT Scans
2) By Nucleic Acid Testing: Polymerase Chain Reaction (PCR), Nucleic Acid Amplification Tests (NAATs)
3) By Cytokine Detection Tests: Interferon Gamma Release Assays (IGRAs)
4) By Drug Resistance Tests: GeneXpert MTB/RIF, Line Probe Assays
5) By Skin Test or Mantoux Test (TST): Tuberculin Skin Test (TST)
6) By Blood Or Serology Test: Serological Tests for Antibodies
7) By Smear Microscopy Tests: Acid-Fast Bacilli (AFB) Smear Test
8) By Cell Culture-Based Tests: Solid Media Cultures, Liquid Media Cultures
9) By Other Test Types: Molecular Tests, Advanced Imaging Techniques

What Key Trends Are Driving Growth In The Tuberculosis Diagnostics Market?
The tuberculosis diagnostics market is seeing a growing trend in technological advancements. High-profile businesses in the market are leveraging cutting-edge technologies like AI-based point-of-care (POC) diagnostics to maintain their market dominance. Notably, in August 2022, Fujifilm, a Japanese firm specializing in the production of medical imaging devices, collaborated with Qure.ai, an American company known for creating AI-powered medical imaging solutions. Their joint venture resulted in an advanced POC diagnostic methodology which employs a battery-operated X-ray machine for diagnosing tuberculosis. Propped up by artificial intelligence, these algorithms enhance the testing programs by providing highly portable, accurate, and effective POC diagnostic options.

Who Are The Major Stakeholders Operating In The Tuberculosis Diagnostics Market?
Major companies operating in the tuberculosis diagnostics market include Beckton, Dickinson and Company, F. Hoffmann-La Roche Ltd, Qiagen N.V, BioMerieux SA, Danaher Corporation, PerkinElmer, Thermo Fisher Scientific Inc., Creative Diagnostics, Lionex GmbH, Biocartis, Bio-Techne India Private Limited, Bio-Rad laboratories India Pvt.Ltd, Zhejiang Di’an Diagnostics Technology Co., Ltd, ADICON Clinical Laboratories, Guangzhou Kingmed Diagnostics Center Co. Ltd., Kindstar Global, OriGene Technologies, Siemens AG, LumiraDx Limited, TestLine Clinical Diagnostics s.r.o., Hologic, Bayer AG, Meridian Bioscience, Abbott laboratories Immunodiagnostic Systems Holdings PLC, Mesa Biotech Inc, Agilent technologies Inc, Akonni Biosystems Inc, Epistem Limited, Gen-Probe, Sysmex South Africa (Pty) Ltd., Bio Certica, BixBio

Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/tuberculosis-diagnostics-global-market-report

How Do Regional Dynamics Influence The Tuberculosis Diagnostics Market Performance?
Asia-Pacific was the largest region in the tuberculosis diagnostics market in 2024. The regions covered in the tuberculosis diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=8165&type=smp

Browse Through More Reports Similar to the Global Tuberculosis Diagnostics Market 2025, By The Business Research Company

Respiratory Disposables Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/respiratory-disposables-global-market-report

Respiratory Devices And Equipment Therapeutic Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/respiratory-devices-and-equipment-therapeutic-global-market-report

Respiratory Devices And Equipment Therapeutic And Diagnostic Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/respiratory-devices-and-equipment-therapeutic-and-diagnostic-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model